Stoicheia

Stoicheia is a nanotechnology company focused on the high-throughput discovery of new materials using its proprietary Megalibrary platform. The company's technology, based on the work of Dr. Chad Mirkin, allows for the synthesis and screening of millions of unique nanoparticles simultaneously to identify optimal structures for specific applications. While currently focused on catalysis and energy storage, the platform has significant implications for the development of novel diagnostics and drug delivery systems. Stoicheia aims to accelerate the materials development cycle from decades to months by combining nanolithography with artificial intelligence. The company's approach digitizes the discovery process, enabling the exploration of a vast chemical space that was previously inaccessible.